Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

about

Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

Item

http://www.wikidata.org/entity/Q38844669

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

@en

type

Item

label

Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

@en

prefLabel

Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

@en

P1476

Blast-phase myeloproliferative neoplasms: risk factors and treatment approaches.

@en

P2093

Kristen Pettit

http://www.w3.org/2001/XMLSchema#string

Olatoyosi Odenike

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474086.2016.1210004

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27385032

http://www.w3.org/2001/XMLSchema#string